Market Place
Sourcing Support
Immunocore Reveals Strategic Priorities At J.P. Morgan Conference
10 Jan 2025 //
GLOBENEWSWIRE
Immunocore to present at the 43rd Annual J.P. Morgan Conference
06 Jan 2025 //
GLOBENEWSWIRE
Immunocore Appoints Travis Coy as CFO & Corporate Development
02 Jan 2025 //
GLOBENEWSWIRE
Immunocore Doses First Patient in Phase 1 IMC-P115C Trial
23 Dec 2024 //
GLOBENEWSWIRE
Immunocore 1st Patient in Ph 1/2 Trial of IMC-R117C for GI Cancers
17 Dec 2024 //
GLOBENEWSWIRE
EORTC & Immunocore Enroll 1st Patient in Uveal Melanoma Trial
11 Dec 2024 //
GLOBENEWSWIRE
Immunocore Announces KIMMTRAK? Reimbursement For Uveal Melanoma
02 Dec 2024 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
08 Nov 2024 //
GLOBENEWSWIRE
Immunocore reports Q3 financial results & provides business update
06 Nov 2024 //
GLOBENEWSWIRE
Immunocore Presents Brenetafusp Phase 1 Data In Ovarian Cancer
14 Sep 2024 //
GLOBENEWSWIRE
Immunocore to present at the 2024 Cantor Global Healthcare Conference
12 Sep 2024 //
GLOBENEWSWIRE
Immunocore announces transition of Chief Financial Officer
29 Aug 2024 //
GLOBENEWSWIRE
Immunocore Reports Q2 Financial Results And Provides Business Update
08 Aug 2024 //
GLOBENEWSWIRE
Immunocore To Report Q2 2024 Results On August 8
01 Aug 2024 //
GLOBENEWSWIRE
Immunocore`s Kimmtrak (tebentafusp) Receives Suppl Approval in US
26 Jun 2024 //
FDA
Immunocore Randomizes First Patient In Phase 3 Trial For Brenetafusp In Melanoma
18 Jun 2024 //
GLOBENEWSWIRE
KIMMTRAK Data: SD/Tumor Reduction Similar To Partial Response Outcomes
01 Jun 2024 //
GLOBENEWSWIRE
Immunocore`s Brenetafusp Data In Pretreated Melanoma At ASCO 2024
31 May 2024 //
GLOBENEWSWIRE
Immunocore to present at the Jefferies Global Healthcare Conference
30 May 2024 //
GLOBENEWSWIRE
Immunocore Converts TEBE-AM To Registrational Phase 3 In Melanoma
29 May 2024 //
GLOBENEWSWIRE
Immunocore Q1 2024 Results, Business Update
08 May 2024 //
GLOBENEWSWIRE
Immunocore announces upcoming presentation and posters at ASCO 2024
24 Apr 2024 //
GLOBENEWSWIRE
Immunocore to Present at Upcoming Investor Conferences
04 Apr 2024 //
GLOBENEWSWIRE
Immunocore presented two posters at CROI 2024
05 Mar 2024 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
01 Mar 2024 //
GLOBENEWSWIRE
Immunocore reports fourth quarter and full year 2023 financial results
28 Feb 2024 //
GLOBENEWSWIRE
Immunocore announces clinical trial collaboration and supply agreement with BMS
22 Feb 2024 //
GLOBENEWSWIRE
Immunocore to report fourth quarter and full year 2023 financial results
21 Feb 2024 //
GLOBENEWSWIRE
Immunocore Prices Upsized Convertible Senior Notes Offering
30 Jan 2024 //
GLOBENEWSWIRE
Immunocore Announces Proposed Convertible Senior Notes Offering
29 Jan 2024 //
GLOBENEWSWIRE
Immunocore announces strategic priorities and pipeline expansion
05 Jan 2024 //
GLOBENEWSWIRE
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
Immunocore announces upcoming poster presentations at SITC
01 Nov 2023 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
30 Oct 2023 //
GLOBENEWSWIRE
Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates
26 Oct 2023 //
NASDAQ
Immunocore presents three-year overall survival data from KIMMTRAK Phase 3 trial
21 Oct 2023 //
GLOBENEWSWIRE
Immunocore announces upcoming presentation and posters at ESMO 2023
06 Oct 2023 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
11 Sep 2023 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
01 Sep 2023 //
GLOBENEWSWIRE
Immunocore Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
PRESS RELEASE
Immunocore to report second quarter 2023 financial results
03 Aug 2023 //
PRESS RELEASE
Immunocore presents additional ctDNA data from KIMMTRAK Phase 3 trial at ASCO
03 Jun 2023 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
01 Jun 2023 //
GLOBENEWSWIRE
Immunocore Reports 1Q 2023 FYR and Provides Business Update
10 May 2023 //
PRESS RELEASE
Immunocore to present at the Bank of America Securities 2023 Health Conference
03 May 2023 //
GLOBENEWSWIRE
Immunocore presents new KIMMTRAK data confirming association between early ctDNA
18 Apr 2023 //
GLOBENEWSWIRE
Immunocore Holdings plc`s (NASDAQ:IMCR) Share Price Not Quite Adding Up
17 Apr 2023 //
FINANCE YAHOO
Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 //
GLOBENEWSWIRE
Immunocore to present four posters at AACR Annual Meeting 2023
14 Mar 2023 //
PRESS RELEASE
Immunocore to present at upcoming investor conferences
28 Feb 2023 //
GLOBENEWSWIRE
Immunocore to Report Fourth Quarter and Full Year 2022 Earnings
23 Feb 2023 //
GLOBENEWSWIRE
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data
22 Feb 2023 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
01 Feb 2023 //
GLOBENEWSWIRE
Immunocore announces priorities including pipeline expansion for 2023 -2024
09 Jan 2023 //
GLOBENEWSWIRE
Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 //
GLOBENEWSWIRE
Immunocore is awarded the Prix Galien France award for KIMMTRAK
15 Dec 2022 //
GLOBENEWSWIRE
Immunocore presents ovarian cancer expansion data for ImmTAC® IMC-C103C
08 Dec 2022 //
GLOBENEWSWIRE
Immunocore` Biologic Kimmtrak (Tebentafusp) Receives Approval in the U.S.
29 Nov 2022 //
FDA
